Generative AI Market Report 2024-2029: Healthcare will be the Leading Industry Vertical for Generative AI through 2029 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Generative AI Market by Technology, Component, Application, Industry Vertical, and Region 2024-2029” report has... Read more.
Vanguard Renewables Welcomes Foremost Farms USA to the Farm Powered Strategic Alliance
Foremost Farms is the most recent company to join a national movement to turn food waste into renewable energy BOSTON–(BUSINESS WIRE)–Vanguard Renewables®,... Read more.
MGRC Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of McGrath RentCorp Is Fair to Shareholders
NEW YORK–(BUSINESS WIRE)–Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of McGrath RentCorp (NASDAQ: MGRC) to WillScot... Read more.
SkyWater Technology to Announce Fourth Quarter Financial Results on February 26, 2024
BLOOMINGTON, Minn.–(BUSINESS WIRE)–SkyWater Technology (NASDAQ: SKYT), the trusted technology realization partner, today announced that it intends to... Read more.
Verastem Oncology Outlines Key 2024 Strategic Priorities and Upcoming Catalysts for Advancing Avutometinib and Defactinib and Broader Pipeline in RAS Pathway-Driven Cancers
Expect to Begin Rolling Submission of New Drug Application (NDA) for Accelerated Approval to FDA for Avutometinib and Defactinib Regimen in Recurrent Low-Grade Serous... Read more.
Harrow Announces New Appointments to its Board of Directors
NASHVILLE, Tenn.–(BUSINESS WIRE)–$HROW–Harrow (Nasdaq: HROW), a leading U.S. eyecare pharmaceutical company, today announced the appointments of... Read more.
Jury Rules in Favor of Natera in Patent Infringement Lawsuit Against CareDx; Awards $96.3 Million in Damages to Natera in Lost Profits and Past Royalties
Liability for future sales to be determined AUSTIN, Texas–(BUSINESS WIRE)–Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today... Read more.
REV Group, Inc. to Exit School and Transit Bus Manufacturing and Reorganize Into Two Reporting Segments; Announces a Special Cash Dividend
BROOKFIELD, Wis.–(BUSINESS WIRE)–REV Group, Inc. (NYSE: REVG), a manufacturer of industry-leading specialty vehicle brands, announced today a series... Read more.
Sarepta Therapeutics Announces Positive Data from Part B of MOMENTUM, a Phase 2 Study of SRP-5051 in Patients with Duchenne Muscular Dystrophy Amenable to Skipping Exon 51
At target dose (~30 mg/kg), SRP-5051 dosed monthly resulted in mean dystrophin expression of 5.17% and mean exon skipping of 11.11% at 28 weeks (n=20) The data support... Read more.
Cypress Pointe Surgical Hospital in Louisiana and myBenefits.ai offer DischargePlus™ for post Care Surgeries
SAN FRANCISCO–(BUSINESS WIRE)–Priyam Parikh, the CEO of myBenefits.ai, has expressed his sincere gratitude to Scott Boudreaux, the Chief Operating Officer,... Read more.